Johnson M A, Thompson G K, Mueller T. "一种的合成方法" [P]. US Patent, US 9315099 B2, 2015-07-05.
Davis P L, Klinger H, Mueller T. "Method for the Synthesis of 1-(Piperazin-1-yl)-3,5-di-(pyrollidin-1-yl)-triazine
111668-00-9
2-(piperazin-1-yl)-4,6-di(pyrrolidin-1-yl)-1,3,5-triazine" [P]. US Patent, US 9171018 B2, 2022-06-01.
Anderson J P, Yamamoto T, O'Brien P Q. "A Process for Preparing High-Purity 1-(Piperazin-1-yl)-3,5-di-(pyrollidin-1-yl)-triazine
111668-00-9
2-(piperazin-1-yl)-4,6-di(pyrrolidin-1-yl)-1,3,5-triazine" [P]. US Patent, US 11061129 B2, 2017-05-01.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2016, 2199, (1), 4847-4875.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2024, 2065, (3), 9210-9226.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 1-(Piperazin-1-yl)-3,5-di-(pyrollidin-1-yl)-triazine
111668-00-9
2-(piperazin-1-yl)-4,6-di(pyrrolidin-1-yl)-1,3,5-triazine Using HRMS and NMR". Anal. Chem., 2017, 2208, 4484-4501.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2017, 919, 3710-3735.